Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China flag China · Delayed Price · Currency is CNY
30.28
-1.64 (-5.14%)
May 12, 2026, 3:04 PM CST

SHE:300878 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
181.62137.42253.96330.16162.74280.8
Trading Asset Securities
10.2810.02-245.56--
Cash & Short-Term Investments
191.9147.44253.96575.73162.74280.8
Cash Growth
-27.63%-41.95%-55.89%253.77%-42.04%-52.83%
Accounts Receivable
148.3138.72165.71264.97333.89409.9
Other Receivables
11.8311.6452.1529.1366.312.76
Receivables
160.13150.36217.87294.07700.2412.65
Inventory
54.8260.87118.32153.78116.78129.49
Other Current Assets
23.5824.5826.3328.1654.2747.15
Total Current Assets
430.44383.25616.481,0521,034870.09
Property, Plant & Equipment
752.01759.09853.66857.39761.5706.09
Long-Term Investments
12.512.52526.552519.96
Goodwill
--10.9727.0827.2217.62
Other Intangible Assets
29.9730.0933.5935.6737.5639.31
Long-Term Deferred Tax Assets
32.5135.2354.6727.0716.6324.59
Long-Term Deferred Charges
11.2712.012.515.076.117.03
Other Long-Term Assets
18.7819.0655.4431.176.528.62
Total Assets
1,2871,2511,6522,0621,9151,693
Accounts Payable
26.6347.0178.85101.1295.7597.26
Accrued Expenses
4.268.3144.7452.0924.6153.2
Short-Term Debt
138.3563.3410.01261.9257.2550.06
Current Portion of Long-Term Debt
9.939.9388.21---
Current Portion of Leases
--2.5510.2111.7612.29
Current Income Taxes Payable
17.3621.170.140.262.336.09
Current Unearned Revenue
5.568.7711.1814.715.798.39
Other Current Liabilities
19.1926.894.75.285.585.12
Total Current Liabilities
221.27185.42240.38445.55413.07232.4
Long-Term Debt
89.9689.95186.62149.9533.39-
Long-Term Leases
1.341.715.1813.1816.7119.99
Long-Term Unearned Revenue
40.9742.0338.9242.8332.6525.01
Long-Term Deferred Tax Liabilities
8.378.387.42.037.676.89
Total Liabilities
361.92327.5478.5653.55503.49284.28
Common Stock
144.79144.79144.79144.79144.7980.44
Additional Paid-In Capital
680.77680.77680.77680.77680.77745.12
Retained Earnings
136.62134.88382.11565.05572.29571.76
Treasury Stock
-50-50-50---
Total Common Equity
912.18910.441,1581,3911,3981,397
Minority Interest
13.3713.2916.1617.613.211.71
Shareholders' Equity
925.55923.731,1741,4081,4111,409
Total Liabilities & Equity
1,2871,2511,6522,0621,9151,693
Total Debt
239.58164.94292.57435.24319.182.34
Net Cash (Debt)
-47.68-17.5-38.61140.48-156.36198.46
Net Cash Growth
------65.81%
Net Cash Per Share
-0.33-0.12-0.270.94-1.091.38
Filing Date Shares Outstanding
145.27144.84142.05144.79144.79144.79
Total Common Shares Outstanding
145.27144.84142.05144.79144.79144.79
Working Capital
209.17197.83376.1606.19620.93637.69
Book Value Per Share
6.286.298.159.609.659.65
Tangible Book Value
882.21880.351,1131,3281,3331,340
Tangible Book Value Per Share
6.076.087.849.179.219.26
Buildings
--728.27408.8344.26239.09
Machinery
--264.87307.22286.89162.96
Construction In Progress
--55.1270.43225.09366.57
Source: S&P Global Market Intelligence. Standard template. Financial Sources.